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Objectives: to evaluate the feasibility of endovascular femoropopliteal bypass in combination with remote endarterectomy
of the superficial femoral artery (SFA).
Design: prospective, open study.
Materials: thirteen patients with chronic lower-leg ischaemia due to femoropopliteal occlusive disease underwent 14 SFA
remote endarterectomy procedures followed by endovascular ePTFE femoropopliteal bypass. Primary endografting was
performed in seven cases. The indication for endograft insertion was vessel-wall perforation during endarterectomy in
the remaining seven cases.
Methods: pre- and postoperative clinicl and haemodynamic data were collected and compared. Technical problems and
procedure-related complications were noted.
Results: initial technical success was achieved in all 14 limbs. However, four early reocclusions occurred after 1, 4, 6
and 10 weeks postoperatively. Two late reocclusions were detected after 16 and 22 months without any preceding
symptoms or haemodynamic changes. Primary and secondary patency rates were 61% and 70% at two years, probably
due to graft-related factors, such as lack of radial force, graft folding or kinking, and possibly altered mechanical or
thrombogenetic properties after dilatation of the ePTFE graft.
Conclusions: endovascular femoropopliteal endo-bypass after SFA remote endarterectomy is a feasible procedure. Further
technical improvements are necessary to avoid procedure- and graft-related early failures.
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Introduction initial clinical results of this less-invasive technique
were encouraging, but a high incidence of recurrent
stenosis due to intimal hyperplasia have been re-Endovascular procedures have continued on their
ported.11evolutionary path towards achieving optimum re-
Recent developments in the treatment of SFA oc-vascularisation with minimal invasiveness. Standard
clusive disease have focused on the combination ofballoon angioplasty (PTA) has, by and large, performed
recanalisation and endoluminal grafting.12–16 The po-well in the treatment of focal superficial femoral artery
tential advantage of endovascular lining with a trans-(SFA) occlusive disease, but the results are rather
luminally placed endoluminal graft (TPEG) is todisappointing when treating long SFA occlusions.1–4
reduce restenosis and subsequent SFA reocclusion.The addition of endovascular stents in the SFA has
Therefore, SFA remote endarterectomy followed bynot led to better long-term patency results in several
endoluminal bypass has been suggested. Completerandomised trials.5–6 Semi-closed endarterectomy is
removal of the atherosclerotic intimal core could facili-another option aside from conventional bypass with
tate endograft insertion and reduce external com-comparable long-term patency rates of 67–71% at five
pression from the vessel wall. Vessel lumen reductionyears.7–9 The advent of ring-strip cutter device has
due to the myoproliferative response may be lessmade it possible to perform a remote endarterectomy
exuberant as the endarterectomised segment is coveredof the entire SFA through a single groin incision.10 The
with an endograft, so as to inhibit direct contact of
the vessel wall with the blood flow. Moreover, this
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technique would eliminate the conventional end-to-Vascular Surgery, The Baronie Hospital, Langendijk 75, 4819 EV,
Breda, The Netherlands. side anastomosis that is a notorious site for intimal
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hyperplasia and graft thrombosis due to inherent flow to the distal portion of the graft with two sutures of
6-0 polypropylene (Ethicon, Somerville, NY, U.S.A.)disturbances.17
The purpose of this study was to evaluate the feas- The stent-graft combination was then co-axially moun-
ted on a 6- or 7-mm·4 cm (5 Fr) balloon angioplastyibility of endoluminal grafting. We describe our early
experience with SFA remote endarterectomy followed catheter (Opta 6, Cordis, Miami, FLA, U.S.A.) and
placed within a 30-cm (12 Fr) introduction sheathby the insertion of a self-made endovascular femoro-
popliteal bypass. (Cook, Bloomington, IND, U.S.A.) which was inserted
into the disobliterated SFA. After the endovascular
bypass was properly positioned at the distal endpoint
under fluoroscopic control, the stent was deployed to
Materials and Methods anchor the graft and the introduction sheath was
removed gradually. The TPEG was then dilated up
Between February 1995 and January 1998, fourteen to 6 or 7 mm sequentially from distal to proximal.
limbs in 13 patients underwent endoluminal graft Completion angiography was performed before clos-
implantation combined with remote endarterectomy. ure in all cases. The proximal end of the PTFE graft
The reason for endograft placement was extravasation was finally cut and sutured as a patch plasty into the
during remote endarterectomy procedures in seven orifice of the SFA. All patients received intraoperative
cases. In seven cases primary endograft placement was heparin during the procedure.
planned. This study was approved by our Institutional Duplex scanning (HP Sonos 2000, Hewlett Packard
Review Board and informed consent was obtained Company, Imaging Systems Division, Andover, MA,
from all patients. Demographic data and risk factors U.S.A.) was performed as part of our surveillance
for atherosclerosis were collected from the patients’ programme within 1–6 weeks and at 3-monthly in-
medical records. Preoperative assessment included tervals during the first year. The severity of restenosis
measurement of Doppler ankle–brachial blood pres- was determined according to previously validated
sure index (ABPI), treadmill tests and arteriography criteria from our institution as published by Legemate
for the evaluation of chronic lower-extremity isch- et al.20 Local increase of peak systolic velocity (PSV) at
aemia and the femoropopliteal lesions (stenosis/oc- the site of stenosis (PSV–max) was compared with
clusions). Aortoiliac inflow vessels were evaluated the peak systolic velocity of a nearby normal arterial
either by angiography and/or duplex scanning. The segment (PSV–normal). A PSV ratio (PSV–max/PSV–
indications for operation were assessed using the ‘Sug- normal) >2.5 was considered a 50% diameter reduction
gested standards for reports dealing with lower ex- (DR) or more. Clinical and haemodynamic status were
tremity ischemia’ by Rutherford et al.18 All patients evaluated by recurrent symptoms and ankle–brachial
had long segmental SFA occlusion not suitable for PTA blood-pressure-index measurements at every follow-
with a patent supragenicular popliteal artery and at up visit. Patients were given oral anticoagulants one
least one crural run-off vessel (Fig. 1). Patients who day prior to surgery and this was continued for a
had undergone previous femoropopliteal in- minimum of 6 months. Thereafter, this was changed
terventions were not excluded from this study. for antiplatelet drugs.
All procedures were performed by a vascular sur-
geon in close collaboration with an interventional ra-
diologist in the operating room equipped with a Definitions, study endpoints and statistical methods
movable radiolucent surgical table combined with a
digital angiographic system using a ceiling-suspended The primary end-point was any reocclusion, and radio-
logical or surgical intervention prior to occlusion. Sec-C-arm (OPC-9 and DSI, Philips Medical Systems, The
Netherlands). The procedure started with SFA remote ondary end-points were recurrent haemodynamically
significant stenosis detected by duplex scanning orendarterectomy using a ring-strip cutter (Mollring Cut-
terTM, Avatar Inc, Portola Valley, CA, U.S.A.) (Fig. 2). angiography, limb salvage, or death. Immediate tech-
nical success and early and intermediate clinical andThis technique has been described previously.19 After
establishing complete recanalisation of the SFA, a haemodynamic success were analysed according to
the guidelines provided by the Society of Vascularguidewire was positioned in the lumen of the popliteal
artery. The self-made endovascular bypass was com- Surgery and the International Society for Cardio-
vascular Surgery.18 Technical success was defined asposed of a thin-walled 3-mm ePTFE graft (Impra,
Tempe, AZ, U.S.A.) with a small balloon-expandable any recanalisation of occlusive lesions or residual sten-
osis less than 20% (DR) for stenotic lesions on com-Palmaz 204 stent (Johnson & Johnson Interventional
Systems Co, Warren, NJ, U.S.A.). The stent was affixed pletion angiography. Clinical and haemodynamic
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Fig. 1. Preoperative angiography: (a) total occlusion at the level of the proximal superficial femoral artery; (b) proximal from the knee
joint collateral filling of a patent popliteal artery.
success was defined as an improvement of the clinical patients. Four patients had a medical history of
(attempted) angioplasty in the ipsilateral SFA. Twocategory by one level or the limb status by at least
one point and rise of ABPI >0.10 after the procedure. patients had previously undergone a local en-
darterectomy of the common femoral artery and aCumulative primary and secondary patency rates were
calculated using the life-table method, according to profundaplasty. The indications for operation (SVS/
ISCVS-NA criteria) were chronic lower-extremity isch-the ‘‘Suggested standards for reports dealing with
lower extremity ischemia’’.18 Patency calculations were aemia Category 1–3 in 6, Category 4 in 5, and Category
5 in 3 patients. The median length of the SFA occlusionbased on the number of procedures performed. Dif-
ference of mean ABPI pre- and post-procedurally were was 18 (interquartile range 10–23) cm. The median
compared using the Student t-test. The limit of stat- length of the endarterectomised segment was 33
istical significance was set at p=0.05 (two-sided). (interquartile range 30–36) cm.
Initial technical success was achieved in all 14 cases
(Fig. 3). However, in one patient we had difficulty in
positioning the guidewire in the popliteal artery. TheResults
guidewire eventually re-entered the true distal lumen
after subintimal positioning, which was recognisedFourteen endografts were implanted in ten males and
after deployment of the distal stent. A second stentthree females with a mean (–standard deviation (s.d.))
was deployed and SFA patency was restored andage of 68 (–9.4) years. Co-morbid risk factors for
accepted, despite improper implantation of the TPEG.atherosclerosis included: smoking in 10/13 patients;
The mean (–s.d.) ABPI rose from 0.61 (–0.16) pre-hypertension in 8/13 patients; hypercholesterolaemia
operatively to 0.98 (–0.05) postoperatively (p<0.001).in 6/13 patients, and diabetes mellitus in 5/13 patients.
One patient, who was diabetic and dialysis-dependent,Associated symptomatic coronary disease was present
in 7/13 patients and cerebrovascular disease in 2/13 had severe gangrene of his right foot. He underwent
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Fig. 2. Fluoroscopic image of remote endarterectomy procedure: (a) conventional Vollmar ring stripper at level of distal SFA; (b) activated
ring strip cutter transecting the intima core endoluminally; (c) angiography after removing occluded intima core from SFA. Notice distal
endpoint (arrow) with intima edge before introduction of guidewire and endograft.
Table 1. Life-table analysis for primary patency rates of 14 SFA remote endarterectomy with endovascular femoropopliteal bypass.
Interval No. at risk Failed Duration Loss to Death Interval Cumulative Standard
(months) follow-up patency rate patency (%) error (%)
0–1 14 2 1 0 0 0.85 100.00 0.00
1–6 11 2 0 0 0 0.82 85.19 9.89
6–12 9 0 0 0 0 1.00 69.70 12.79
12–18 9 1 1 0 0 0.88 69.70 12.79
18–24 7 1 5 0 0 0.86 61.50 14.42
successful revascularisation but shortly thereafter a necessitated surgical treatment. This patient recovered
uneventfully. Distal embolisation was not en-below-knee amputation was required, despite a patent
endograft. All other patients initially showed im- countered.
Four early reocclusions occurred after one week,provement of their clinical category by one level or
the limb status by at least one point. No in-hospital four, six, and ten weeks. One patient with claudication
had a graft occlusion at the six weeks follow-up andmortality was noticed. One early procedure-related
complication was observed: a deep groin infection underwent thrombectomy. A second patient with rest
Table 2. Life-table analysis for secondary patency rates of 14 SFA remote endarterectomy with endovascular femoropopliteal bypass.
Interval No. at risk Failed Duration Loss to Death Interval Cumulative Standard
(months) follow-up patency rate patency (%) error (%)
0–1 14 1 0 0 0 0.93 100.00 0.00
1–6 13 2 1 0 0 0.84 92.86 6.88
6–12 10 0 0 0 0 1.00 78.00 11.57
12–18 10 1 0 0 0 0.90 78.00 11.57
18–24 9 1 1 0 0 0.88 70.20 12.77
Eur J Vasc Endovasc Surg Vol 19, January 2000
Endovascular Femoropopliteal Bypass 31
Fig. 3. Completion angiography during and after remote endarterectomy and SFA endograft implantation. (a) The expanded PTFE
endograft is widely patent; (b) with a smooth distal overpass into the popliteal artery.
pain underwent thrombectomy one week following thrombectomy of the endograft, he later underwent a
below-knee amputation.endografting until reocclusion was noted after four
months, but she has not suffered from recurrent critical After a median follow-up of 20.8 (interquartile range
13.2–29.3) months, two late endograft reocclusionslimb ischaemia. In a third case with gangrene and
high outflow resistance, graft occlusion at four weeks occurred after 16 and 22 months postoperatively. The
first patient had been treated for rest pain. Sixteennecessitated a femorocrural bypass which ultimately
could not prevent major amputation. The fourth early months later, he suffered a stroke and was admitted
to the neurology department. Shortly thereafter, isch-failure at ten weeks was the aforementioned patient
with improper TPEG placement. He was initially aemia of his left leg was noted due to occlusion of his
SFA endograft. Ultimately, we decided to perform atreated for a non-healing foot ulcer. Ten weeks after
the first operation, he was re-admitted to undergo a below-knee amputation. The patient with an endograft
that became occluded after 22 months was initiallycorrection of his endograft. It appeared on the an-
giogram that some folding of the endograft had ob- treated for disabling claudication. He was re-admitted
with upper gastrointestinal bleeding and his anti-structed the lumen of the graft proximally. The
endograft was ‘‘pulled up’’ surgically and sutured coagulants were discontinued. Two weeks later he
started to complain of progressive ischaemic leg painagain into the common femoral artery. Intraoperative
angiography showed no folding of the endograft. Four due to occlusion, ultimately resulting in a femoro-
popliteal in situ vein graft. The one- and two-yeardays later the endograft became occluded. Despite
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cumulative primary patency rate was 70% and 61% and results. Obviously, no firm conclusions can be drawn
the secondary patency rate 78% and 70% respectively. from the small numbers of this study. Nevertheless,
During follow-up, one restenosis has been detected femoropopliteal endografting after remote end-
with duplex surveillance after 19 months. The re- arterectomy seems to be a feasible procedure. All
stenosis was located at the proximal part of the endo- procedures were successfully completed, although one
graft without any clinical or haemodynamic effect. TPEG was not inserted properly. This technical prob-
The endograft is still patent after 28 months without lem resulted from malpositioning of the guidewire,
any interventions. which occurred only once. The passage of the guide-
wire may be difficult, even in experienced hands. A
solution to this problem was recently suggested by
Whiteley et al., using a retrograde approach via the
Discussion popliteal artery.30
The early reocclusions are another matter for con-
Endoluminal grafting via the femoral approach was cern. Despite pre-implantation remote endarterectomy
first reported by Volodos’ et al. in 1986.21 The method and completion angiogram to ensure technical ad-
has been developed and refined extensively, par- equacy of the procedure, three out of four early failures
ticularly for the treatment of aneurysmal disease, most occurred within six weeks after endografting. Endo-
experience being gained at aortic sites.22,23 More re- vascular graft twisting, kinking and folding as de-
cently, several studies have been published about en- scribed by Ahn et al., may have caused these early
dovascular grafting to treat femoropopliteal occlusive failures.31 White et al. had similar problems with graft-
disease.16,24–27 An endovascular femoropopliteal bypass narrowing and subsequent thrombosis in the un-
could offer the durability of a standard conventional stented segments of stented grafts in a canine study.32
bypass and the benefit of a less-invasive endovascular They concluded that completely supported (stented)
procedure. grafts as endoluminal prosthesis should be further
Most experience of endovascular grafting has been developed and used. Another mechanism that may
gained without removing the atherosclerotic intima have contributed to endograft compression or oc-core prior to graft insertion. Recanalisation through
clusion is back-bleeding from side-branches afteratherectomy devices or the use of guidewires were
endarterectomy of the SFA. However, we have nocombined with predilatation. This technique might
indications that this was the case in one of our failureslead to increased external endograft compression due
either. Certainly, the self-made endografts can be im-to the natural tendency for elastic recoil of the arterial
proved and perhaps our unsupported endografts arewall after dilatation. However, Spoelstra et al. reported
not adequate. Several fully supported stent graftsa 98% technical success rate in 55 SFA endobypass
like the Cragg Endopro System I (Mintec, La Ciotat,procedures with predilatation only.16 He achieved a
France), its successor the Passager (Boston Scientific,73% primary and 86% secondary patency rate at 12
Meadox Medicals, Oakland, NJ, U.S.A.), and themonths. Stockx used the same technique and device
Hemobahn (Gore, Putzbrunn, Germany) are now com-in 25 patients, but could not duplicate Spoelstra’s
mercially available. Disadvantages of these coveredfavourable results.27 Despite a similar high initial tech-
stents are the scarce clinical data and the maximumnical success rate, more than 50% of the endobypasses
stent length of 15 centimetres only. In the SFA region,occluded within six months. Marin et al., who reported
several stent grafts would then be needed, whichthe first TPEG for the treatment of femoropopliteal
makes the procedure more costly. Fully supportedocclusive disease in 1994 in three patients without
TPEGs have been attempted by Cragg and Dake toarterial debulking, has abandoned femoropopliteal
reduce the risk of graft occlusion, but their experienceendografting with predilatation only (personal com-
is limited.26munication). On the other hand, Bergeron and Morris,
Another cause of early failure may have been alteredwere, like us, proponents of arterial debulking prior
mechanical or thrombogenetic properties of dilatedto endografting to reduce elastic arterial recoil.28,29
ePTFE endografts. Marston et al. found that both 3-With our novel technique of remote endarterectomy
and 4-mm thin-walled ePTFE grafts could easily becombined with femoropopliteal endobypass, the risk
dilated to five times their initial diameter before rup-of graft compression is theoretically eliminated,
ture occurred. PTFE node size was significantly smallertheoretically resulting in improved long-term patency
in dilated grafts, but there was no change in internodalrates.
distance after dilatation.33 Different healing mech-This study was designed to evaluate the feasibility
of this technique and to report on our initial clinical anisms of high-porosity versus standard PTFE grafts
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